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Kainate (KA) is a potent neurotoxin that has been widely used experimentally to induce
acute brain seizures and, after repetitive treatments, as a chronic model of temporal
lobe epilepsy (TLE), with similar features to those observed in human patients with
TLE. However, whether KA activates KA receptors (KARs) as an agonist to mediate
the induction of acute seizures and/or the chronic phase of epilepsy, or whether
epileptogenic effects of the neurotoxin are indirect and/or mediated by other types of
receptors, has yet to be satisfactorily elucidated. Positing a direct involvement of KARs
in acute seizures induction, as well as a direct pathophysiological role of KARs in the
chronic phase of TLE, recent studies have examined the specific subunit compositions
of KARs that might underly epileptogenesis. In the present mini-review, we discuss the
use of KA as a convulsant in the experimental models of acute seizures of TLE, and
consider the involvement of KARs, their subunit composition and the mode of action
in KAR-mediated epilepsy. In acute models, evidence points to epileptogenesis being
precipitated by an overall depression of interneuron GABAergic transmission mediated
by GluK1 containing KARs. On glutamatergic principal cell in the hippocampus, GluK2-
containing KARs regulate post-synaptic excitability and susceptibility to KA-mediated
epileptogenesis. In chronic models, a role GluK2-containing KARs in the hippocampal
CA3 region provokes limbic seizures. Also observed in the hippocampus, is a ‘reactive
plasticity’, where MF sprouting is seen with target granule cells at aberrant synapses
recruiting de novo GluR2/GluR5 heteromeric KARs. Finally, in human epilepsy and
animal models, astrocytic expression of GluK1, 2, 4, and 5 is reported.
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INTRODUCTION
The analog of glutamate kainic acid/kainate (KA) is a potent neurotoxin derived from
the alga Digenea simplex. The word “Kainic” is derived from the Japanese “Kaininso”
(“Makuri”), which means “the ghost of the sea”. KA was first isolated in 1953, from
D. simplex, and therapeutically utilized, given its toxicity towards intestinal worms.
Thereafter, KA was used to induce behavioral and electrophysiological seizures, establishing
a model of temporal lobe epilepsy (TLE), where seizures originated in the hippocampal
CA3 region (Nadler, 1981). Indeed, the toxin produces tissue damage and lesions that
are reminiscent of those observed in human patients with TLE. However, while the
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acute effect of KA in producing seizures is well-established, its
cogency in the clinically relevant chronic phase of TLE remains
to be determined.
Kainate actions are largely mediated by the activation of
kainate receptors (KARs) at which KA is a high affinity
agonist. KARs, together with AMPA and NMDA receptors,
comprise the ionotropic receptors family of glutamate receptors.
Additionally, there is now considerable evidence that KARs
have metabotropic/non-canonical actions (Rodríguez-Moreno
and Sihra, 2007a,b). Given that metabotropic actions have also
been described for AMPA, and recently for NMDA receptors
(Valbuena and Lerma, 2016; Bouvier et al., 2018), the distinction
between the signaling mediated by ionotropic and metabotropic
glutamate receptors is increasingly blurred. KARs are specifically
comprised of GluK1-GluK5 subunits. In expression systems,
GluK1, GluK2, and GluK3 may form homomeric receptors, while
GluK4 and GluK5 form heteromeric receptors in conjunction
with GluK1–3 subunits. Native KARs are widely distributed in
the brain (Bahn et al., 1994), with high densities of receptors
found in the hippocampus, a key structure featuring in TLE.
Hippocampal KARs containing GluK1 subunits are mostly
expressed in interneurons, where the reduction of GABA release
results in the increased excitability of glutamatergic principal
neurons (Clarke et al., 1997; Rodríguez-Moreno et al., 1997, 2000;
Rodríguez-Moreno and Lerma, 1998), or enhance inhibition by
increasing GABA release (Cossart et al., 1998; Frerking et al.,
1998; Jiang et al., 2001). GluK2 subunit containing KARs are
mostly located in excitatory neurons, where they modulate
glutamate release presynaptically (Chittajallu et al., 1996; Vignes
et al., 1998; Contractor et al., 2000, 2001, 2003, Kamiya and
Ozawa, 2000; Schmitz et al., 2000, 2001; Lauri et al., 2001;
Rodríguez-Moreno and Sihra, 2004, 2013; Negrete-Díaz et al.,
2006, 2007, 2012, Pinheiro et al., 2007; Scott et al., 2008;
Fernandes et al., 2009; Lyon et al., 2011; Andrade-Talavera
et al., 2012, 2013; reviewed in Sihra and Rodríguez-Moreno,
2013), and post-synaptically, underpin part of the synaptic
component of excitatory transmission (Castillo et al., 1997;
Vignes et al., 1997). This differential subcellular localization
allows KARs to regulate the actions of neural circuits in the
hippocampus.
Epilepsy is a chronic neurological disorder characterized by
the occurrence of spontaneous recurrent seizures (prolonged and
synchronized neuronal discharges). TLE is the most common
form of human epilepsy. Recurrent seizures originate from
diverse structures, usually the hippocampus, and sometimes
may propagate to the amygdala and the entorhinal cortex
(Lothman et al., 1991). Current antiepileptic drugs that are
effective in controlling seizures in patients with TLE, either
act on voltage- gated Na+ channels and Ca2+ channels, to
modify neuronal excitability, or enhance GABAergic inhibition.
However, although this anticonvulsant drug therapy reduces
overall neuronal excitability in the brain, there are unwanted
side effects (Perucca and Meador, 2005; Goldenberg, 2010). And,
indeed, in many cases where TLE is severe, it is intractable to
current drug therapy. Looking to alternative antiepileptic drug
targets, while the GluK1 subunit-containing KAR represents
a potential candidate (Rogawski et al., 2003), there is no
anticonvulsant therapy based on KARs signaling that is currently
in use in humans.
Models for seizures involving KAR activation can be acute or
chronic. KA or pilocarpine injections represent acute models of
epileptiform seizures. In chronic models, systemic administration
of the aforementioned agents is continued for 1–3 days. In a
high proportion of injected animals treated in this way, after
a lag of some days or weeks without any seizures, a chronic
phase of spontaneous recurrent limbic seizures is precipitated.
These seizures increase in frequency and do not resolve (Ben-Ari,
1985; Leite et al., 1990). KA-induced seizures in animals produce
patterns of activity-induced neuronal and cell loss, astrogliosis
and hippocampal sclerosis of CA1 and CA3 pyramidal cells
(PyC), that resemble characteristics of human TLE (Nadler et al.,
1978; Ben-Ari, 1985).
KAR ROLE IN ACUTE SEIZURES
The majority of studies of KARs related to epilepsy have
investigated the acute effects of KA-induced seizures (Rodríguez-
Moreno et al., 1997; Mulle et al., 1998; Smolders et al.,
2002; Fritsch et al., 2014). KA injection produces an acute
epileptogenesis mediated by KAR-mediated suppression of
presynaptic GABA release, together with post-synaptic KAR
activation of glutamatergic neurons (Rodríguez-Moreno et al.,
1997; reviewed in Lerma and Marques, 2013). However, to date,
there is no explanation for the chronic effect of KA that continues
some months after the KA treatment. Hippocampal interneurons
in the CA1 region of the hippocampus possess GluK1 subunit
containing KARs in the axonal compartment, as well as in the
somatodendritic compartment (Paternain et al., 2000; Rodríguez-
Moreno et al., 2000). KA at interneuron-interneuron synapses
facilitates GABA release, and thus inhibitory drive (Cossart et al.,
1998). At interneurons-principal cells synapses, hippocampal
interneurons manifest a biphasic effect of KA. Activation of
KARs by “high” doses of KA suppresses GABA release (Clarke
et al., 1997; Rodríguez-Moreno et al., 1997), while stimulation
of KARs by “low” KA concentrations, or ATPA (an agonist
of GluK5 subunit containing KARs), facilitates GABA release
(Jiang et al., 2001; Khalilov et al., 2002). However, contrary to
what would be predicted by the latter observation, in vivo, the
systemic administration of ATPA actually induced seizures in
the hippocampus and the amygdala. This effect was contingent
on the presence of GluK1 given that it was abolished in
GluK1−/−mice (Fritsch et al., 2014). Consistent with this, in vivo
antagonism of KARs containing the GluK1 subunit, blocked
seizures induced by the muscarinic receptor agonist pilocarpine
(Smolders et al., 2002). These observations indicate that the
regulation of inhibition is key for the potential action of KA on
KARs and epilepsy. Thus, in vivo, the net effect of the activation of
KARs seems to be an overall depression of GABA release leading
to increased excitation and thereby epileptiform activity. This
is, to date, one of the best pathophysiological demonstrations
of the net effects of KA in epileptgenesis (Rodríguez-Moreno
et al., 1997; Figure 1A). Post-synaptic KARs have also been
found in the principal cells of the hippocampus. Here the KARs
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contain at least one GluK2 subunit, and their activation mediates
the regulation of afterhyperpolarization. Alteration of the latter
affects neuronal excitability and may therefore contribute to
susceptibility to the pro-convulsant effects of KA (Melyan et al.,
2002, 2004).
In agreement with a role of KARs containing GluK1 subunit
in seizure induction, in a study of members of a family affected
by idiopathic juvenile absence epilepsy, there were increased
levels of Grik1 polymorphisms (Sander et al., 1997). Additionally
data from TLE patients also showed that the GluK1 subunit
is upregulated (Li et al., 2010), indicating that there is KAR
reorganization occurring in human epilepsy. Mitigating against
this, the AMPA/KAR antagonist NS1209, has been shown, in
clinical Phase II studies, to alleviate refractory status epilepticus
(Swanson, 2009).
In summary, in ex vivo and in in vivo models, in the
hippocampus and the amygdala, KA has been found to reduce
GABA release. This attenuates the inhibition of hippocampal
pyramidal cells and is thereby posited to provoke epileptic
activity. It has also been shown that the use of antagonists
of GluK1 subunit-containing KARs prevented epileptic activity,
thus corroborating a key role for synaptic inhibition in the
KAR-induced seizures. Post-synaptic KARs activation mediate
an increase in excitability. As a general mechanism then, the
proposal is that the activation of KARs orchestrates an imbalance
between excitation and inhibition, and this represent one way
that KA activating KARs induces acute seizures (Figure 1A).
KARs ROLE IN CHRONIC SEIZURES
Since the 1970s, it has been known that the CA3 region of
the hippocampus is a key area related to the origin of seizures
(reviewed in Ben-Ari and Cossart, 2000). KARs containing the
GluK2 subunit have been linked to limbic epilepsies because of
its specific distribution in CA3 pyramidal neurons (Werner et al.,
1991). Consistent with a direct role of KARs in the induction
of epilepsy in this region, the ablation of GluK2 subunits in
knockout studies reduced the sensitivity of the mice to develop
seizures after KA injection (Mulle et al., 1998).
In animal models of TLE and human patients, neuronal
tissue undergoes major reorganization, where some neurons
die and others sprout and make aberrant connections (Ben-
Ari et al., 2008). This “reactive plasticity” is well-described
in the dentate gyrus of the hippocampus. Here, mossy fibers
(MFs), the axons of granule cells (GCs) from the dentate gyrus
and where KARs are highly expressed, undergo sprouting after
KA injections and form a functional recurrent MF network
(Tauck and Nadler, 1985; Represa et al., 1987; Sutula and
Dudek, 2007). MF sprouting is therefore considered as one of
the pathological characteristics of TLE in humans and animal
models. Interestingly, at these aberrant synapses developed under
pathological conditions, ‘de novo’ KARs are expressed in the
GCs of the dentate gyrus, and these likely participate in the
pathogenesis of TLE (Epsztein et al., 2005; Artinian et al., 2011,
2015). KA mediates glutamatergic currents at MF-GC synapses,
and some half of the glutamatergic transmission has been
proposed to be due to the insertion of these new KARs (Epsztein
et al., 2005; Peret et al., 2014; reviewed in Vincent and Mulle,
2009; Crépel and Mulle, 2015). The consequence of the insertion
of KARs in GC would be the generation of a hyperexcitable
circuit in the hippocampal dentate gyrus. This may ultimately
produce epileptiform activity, particularly when inhibition by
GABAergic transmission is simultaneously depressed (Epsztein
et al., 2005).
The aforementioned aberrantly inserted post-synaptic KARs
are likely heteromeric receptors containing GluK2/GluK5
subunits, that can be blocked by the specific antagonist for post-
synaptic MF KARs, UBP310 (Pinheiro et al., 2013). GluK2, 4, and
5 subunits have been found at post-synaptic sites (Mulle et al.,
1998; Contractor et al., 2003; Fernandes et al., 2009), and are
involved in generation of recurrent seizures in chronic epilepsy.
Presynaptic MF KARs comprise GluK2 and GluK3 subunits, and
mediate facilitation or depression of glutamate release, and are
thereby involved in presynaptic plasticity (reviewed in Sihra and
Rodríguez-Moreno, 2013; Sihra et al., 2014). The de novo KARs
present in dentate gyrus GC impair temporal precision of EPSP-
spike coupling and thus induce seizures by altering the basally
sparse firing rate of dentate gyrus GCs (Artinian et al., 2011,
2015). Additionally it is known that the CA3 synaptic silencing
attenuated KA induced seizures and network oscillations in the
hippocampus (Yu et al., 2016).
The study of the role of the aforementioned new/aberrant
KARs in the chronic phase of TLE in the pilocarpine model of
chronic TLE showed that the inter-ictal and ictal events were
reduced in mice lacking GluK2 subunit, but not those lacking
GluK1, or with the use of a GluK2/GluK5 antagonist (Peret
et al., 2014). These results suggest that these KARs may represent
targets for antiepileptic drugs (Figure 1B). KARs also modulate
intrinsic conductance by a metabotropic action at MF-CA3
synapses (Fisahn et al., 2004). It remains to be elucidated how
aberrant KARs are recruited to the membrane and whether these
abnormally expressed post-synaptic KARs in dentate gyrus GCs
are activated by endogenous glutamate, to develop and propagate
seizures in the hippocampus. However, it has recently been
shown that C1q-like proteins (related to the C1q complement
component) may have a role at MFs (Matsuda et al., 2016). C1ql2
and C1ql3 proteins produced by MFs have been demonstrated
to serve as extracellular organizers to recruit functional post-
synaptic KAR complexes to the CA3 pyramidal neurons and GCs
(Figure 1B).
POSSIBLE ROLE OF ASTROCYTES IN
KA INDUCED SEIZURES
In the recent years, evidence has accumulated to suggest that
astrocytes may have an important role in KA-induced seizures.
In tissue from patients with refractory TLE, an increase of KARs
subunits GluK4 and GluK5 have been reported (Das et al., 2012).
Surprisingly, KARs subunits GluK1, 2, 4, and 5 are all expressed
in astrocytes, 1 week after the induction of status epilepticus in
the CA1 region of the hippocampus of treated animals, but not
in naïve animals. Further, GluK1 and GluK5 subunits remain
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FIGURE 1 | Possible mechanisms involving KARs in epilepsy. (A) KARs activation depress GABA release what together with the activation of post-synaptic KARs
increase excitability of principal cells. IAHP, afterhyperpolarization potassium current is decreased by KARs activation increasing neuronal excitability. (B) KARs
induce “reactive plasticity” and mediate the insertion of new post-synaptic KARs at granule cells (GCs) of dentate gyrus altering spiking. C1ql2/3 (C1q-like proteins,
related to the C1q complement component) recruit KARs at GCs after pilocarpine treatment. (C) KA or pilocarpine treatments mediate the insertion of KARs in
astrocytes that probably releases gliotransmitter’s to participate in protection of induction of epilepsy.
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enhanced in the chronic phase of epilepsy when spontaneous
seizures occurs (Vargas et al., 2013). The role of the newly
expressed KARs in the astrocytes is currently unclear. Indeed,
it is unknown whether this recruitment of KARs in astrocytes
impinges on the induction and propagation of seizures (as
activation of these KARs might mediate the release of glutamate
from astrocytes), or have just the opposite effect, viz. a
protective role. Future work will be needed to determine
the exact role of astrocytes and astrocytic KARs in epilepsy
(Figure 1C).
FUTURE DIRECTIONS
One important aspect that awaits resolution is whether the
KARs involved in the induction of acute or chronic seizures are
activated directly by endogenously released glutamate. Further,
the precise mechanism by which the loss of excitatory/inhibitory
balance induces seizures and their propagation requires
evaluation. Importantly, the role of “reactive plasticity” in
epilepsy, as a general or basic mechanism for epilepsy, needs to be
expounded and clarified. Finally, the function of astrocytic KARs
and astrocytes in epilepsy requires explication, as to whether their
involvement is pro- or anti-epileptogenic.
In conclusion, three approximations are promising
mechanisms in determining the role of KARs in epilepsy:
(i) depression of inhibitory synaptic transmission and increase in
excitatory transmission (i.e., disruption of excitation/inhibition
balance); (ii) induction of reactive plasticity with new KARs
changing network properties; and (iii) the emerging role
of astrocytes in epilepsy. These three working hypotheses
await further development to understand the exact role of
the intriguing KARs in epilepsy etiology, and facilitate the
elaboration of novel, and hopefully more efficacious, therapies
for epilepsy.
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